Pronovotx
2 known investors
ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia. The company applies a precision-medicine approach based on genetic susceptibility, disease pathophysiology, and biomarkers to advance preclinical drug programs toward clinical development.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Pronovotx do?
- ProNovo Therapeutics is a biotechnology company developing precision small-molecule therapeutics for neuropsychiatric disorders, including Major Depressive Disorder and Schizophrenia. The company applies a precision-medicine approach based on genetic susceptibility, disease pathophysiology, and biomarkers to advance preclinical drug programs toward clinical development.
- Who founded Pronovotx?
- Pronovotx was founded by Guang Chen, Xiaohu Deng, Scott Thompson.
- Who are Pronovotx's investors?
- Pronovotx's investors include 3E Bioventures Capital, Gaorong Ventures.